Global Glioblastoma Multiforme Treatment Market Outlook 2018-2023 Industry Trends, Analysis, Opportunities, Segmentation and Forecast


 Published Date : Jul-2018  |   Publisher : Reports Buzz  |   Format : PDF

 Buy Now

This report studies the global Glioblastoma Multiforme Treatment market, analyzes and researches the Glioblastoma Multiforme Treatment development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like
    AbbVie, Inc
    Activartis GmbH
    Agenus Inc
    Arog Pharmaceuticals, Inc
    Bristol-Myers Squibb Company
    Cavion LLC
    Celldex Therapeutics Inc
    Cortice Biosciences
    Exelixis Inc
    F. Hoffmann-La Roche Ltd.

Market segment by Regions/Countries, this report covers
    United States
    EU
    Japan
    China
    India
    Southeast Asia

Market segment by Type, the product can be split into
    Bevacizumab (Avastin)
    Carmustine (BiCNU)
    Temozolomide (Temodar and Temodal and Temcad)

Market segment by Application, Glioblastoma Multiforme Treatment can be split into
    Hospital
    Clinic
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Global Glioblastoma Multiforme Treatment Market Size, Status and Forecast 2025
1 Industry Overview of Glioblastoma Multiforme Treatment
    1.1  Glioblastoma Multiforme Treatment Market Overview
        1.1.1 Glioblastoma Multiforme Treatment Product Scope
        1.1.2 Market Status and Outlook
    1.2 Global Glioblastoma Multiforme Treatment Market Size and Analysis by Regions (2013-2018)
        1.2.1 United States
        1.2.2 EU
        1.2.3 Japan
        1.2.4 China
        1.2.5 India
        1.2.6 Southeast Asia
    1.3 Glioblastoma Multiforme Treatment Market by Type
        1.3.1 Bevacizumab (Avastin)
        1.3.2 Carmustine (BiCNU)
        1.3.3 Temozolomide (Temodar and Temodal and Temcad)
    1.4 Glioblastoma Multiforme Treatment Market by End Users/Application
        1.4.1 Hospital
        1.4.2 Clinic
        1.4.3 Others

2 Global Glioblastoma Multiforme Treatment Competition Analysis by Players
    2.1 Glioblastoma Multiforme Treatment Market Size (Value) by Players (2013-2018)
    2.2 Competitive Status and Trend
        2.2.1 Market Concentration Rate
        2.2.2 Product/Service Differences
        2.2.3 New Entrants
        2.2.4 The Technology Trends in Future

3 Company (Top Players) Profiles
    3.1 AbbVie, Inc
        3.1.1 Company Profile
        3.1.2 Main Business/Business Overview
        3.1.3 Products, Services and Solutions
        3.1.4 Glioblastoma Multiforme Treatment Revenue (Million USD) (2013-2018)
        3.1.5 Recent Developments
    3.2 Activartis GmbH
        3.2.1 Company Profile
        3.2.2 Main Business/Business Overview
        3.2.3 Products, Services and Solutions
        3.2.4 Glioblastoma Multiforme Treatment Revenue (Million USD) (2013-2018)
        3.2.5 Recent Developments
    3.3 Agenus Inc
        3.3.1 Company Profile
        3.3.2 Main Business/Business Overview
        3.3.3 Products, Services and Solutions
        3.3.4 Glioblastoma Multiforme Treatment Revenue (Million USD) (2013-2018)
        3.3.5 Recent Developments
    3.4 Arog Pharmaceuticals, Inc
        3.4.1 Company Profile
        3.4.2 Main Business/Business Overview
        3.4.3 Products, Services and Solutions
        3.4.4 Glioblastoma Multiforme Treatment Revenue (Million USD) (2013-2018)
        3.4.5 Recent Developments
    3.5 Bristol-Myers Squibb Company
        3.5.1 Company Profile
        3.5.2 Main Business/Business Overview
        3.5.3 Products, Services and Solutions
        3.5.4 Glioblastoma Multiforme Treatment Revenue (Million USD) (2013-2018)
        3.5.5 Recent Developments
    3.6 Cavion LLC
        3.6.1 Company Profile
        3.6.2 Main Business/Business Overview
        3.6.3 Products, Services and Solutions
        3.6.4 Glioblastoma Multiforme Treatment Revenue (Million USD) (2013-2018)
        3.6.5 Recent Developments
    3.7 Celldex Therapeutics Inc
        3.7.1 Company Profile
        3.7.2 Main Business/Business Overview
        3.7.3 Products, Services and Solutions
        3.7.4 Glioblastoma Multiforme Treatment Revenue (Million USD) (2013-2018)
        3.7.5 Recent Developments
    3.8 Cortice Biosciences
        3.8.1 Company Profile
        3.8.2 Main Business/Business Overview
        3.8.3 Products, Services and Solutions
        3.8.4 Glioblastoma Multiforme Treatment Revenue (Million USD) (2013-2018)
        3.8.5 Recent Developments
    3.9 Exelixis Inc
        3.9.1 Company Profile
        3.9.2 Main Business/Business Overview
        3.9.3 Products, Services and Solutions
        3.9.4 Glioblastoma Multiforme Treatment Revenue (Million USD) (2013-2018)
        3.9.5 Recent Developments
    3.10 F. Hoffmann-La Roche Ltd.
        3.10.1 Company Profile
        3.10.2 Main Business/Business Overview
        3.10.3 Products, Services and Solutions
        3.10.4 Glioblastoma Multiforme Treatment Revenue (Million USD) (2013-2018)
        3.10.5 Recent Developments

4 Global Glioblastoma Multiforme Treatment Market Size by Type and Application (2013-2018)
    4.1 Global Glioblastoma Multiforme Treatment Market Size by Type (2013-2018)
    4.2 Global Glioblastoma Multiforme Treatment Market Size by Application (2013-2018)
    4.3 Potential Application of Glioblastoma Multiforme Treatment in Future
    4.4 Top Consumer/End Users of Glioblastoma Multiforme Treatment

5 United States Glioblastoma Multiforme Treatment Development Status and Outlook
    5.1 United States Glioblastoma Multiforme Treatment Market Size (2013-2018)
    5.2 United States Glioblastoma Multiforme Treatment Market Size and Market Share by Players (2013-2018)
    5.3 United States Glioblastoma Multiforme Treatment Market Size by Application (2013-2018)

6 EU Glioblastoma Multiforme Treatment Development Status and Outlook
    6.1 EU Glioblastoma Multiforme Treatment Market Size (2013-2018)
    6.2 EU Glioblastoma Multiforme Treatment Market Size and Market Share by Players (2013-2018)
    6.3 EU Glioblastoma Multiforme Treatment Market Size by Application (2013-2018)

7 Japan Glioblastoma Multiforme Treatment Development Status and Outlook
    7.1 Japan Glioblastoma Multiforme Treatment Market Size (2013-2018)
    7.2 Japan Glioblastoma Multiforme Treatment Market Size and Market Share by Players (2013-2018)
    7.3 Japan Glioblastoma Multiforme Treatment Market Size by Application (2013-2018)

8 China Glioblastoma Multiforme Treatment Development Status and Outlook
    8.1 China Glioblastoma Multiforme Treatment Market Size (2013-2018)
    8.2 China Glioblastoma Multiforme Treatment Market Size and Market Share by Players (2013-2018)
    8.3 China Glioblastoma Multiforme Treatment Market Size by Application (2013-2018)

9 India Glioblastoma Multiforme Treatment Development Status and Outlook
    9.1 India Glioblastoma Multiforme Treatment Market Size (2013-2018)
    9.2 India Glioblastoma Multiforme Treatment Market Size and Market Share by Players (2013-2018)
    9.3 India Glioblastoma Multiforme Treatment Market Size by Application (2013-2018)

10 Southeast Asia Glioblastoma Multiforme Treatment Development Status and Outlook
    10.1 Southeast Asia Glioblastoma Multiforme Treatment Market Size (2013-2018)
    10.2 Southeast Asia Glioblastoma Multiforme Treatment Market Size and Market Share by Players (2013-2018)
    10.3 Southeast Asia Glioblastoma Multiforme Treatment Market Size by Application (2013-2018)

11 Market Forecast by Regions, Type and Application (2018-2025)
    11.1 Global Glioblastoma Multiforme Treatment Market Size (Value) by Regions (2018-2025)
        11.1.1 United States Glioblastoma Multiforme Treatment Revenue and Growth Rate (2018-2025)
        11.1.2 EU Glioblastoma Multiforme Treatment Revenue and Growth Rate (2018-2025)
        11.1.3 Japan Glioblastoma Multiforme Treatment Revenue and Growth Rate (2018-2025)
        11.1.4 China Glioblastoma Multiforme Treatment Revenue and Growth Rate (2018-2025)
        11.1.5 India Glioblastoma Multiforme Treatment Revenue and Growth Rate (2018-2025)
        11.1.6 Southeast Asia Glioblastoma Multiforme Treatment Revenue and Growth Rate (2018-2025)
    11.2 Global Glioblastoma Multiforme Treatment Market Size (Value) by Type (2018-2025)
    11.3 Global Glioblastoma Multiforme Treatment Market Size by Application (2018-2025)

12 Glioblastoma Multiforme Treatment Market Dynamics
    12.1 Glioblastoma Multiforme Treatment Market Opportunities
    12.2 Glioblastoma Multiforme Treatment Challenge and Risk
        12.2.1 Competition from Opponents
        12.2.2 Downside Risks of Economy
    12.3 Glioblastoma Multiforme Treatment Market Constraints and Threat
        12.3.1 Threat from Substitute
        12.3.2 Government Policy
        12.3.3 Technology Risks
    12.4 Glioblastoma Multiforme Treatment Market Driving Force
        12.4.1 Growing Demand from Emerging Markets
        12.4.2 Potential Application

13 Market Effect Factors Analysis
    13.1 Technology Progress/Risk
        13.1.1 Substitutes
        13.1.2 Technology Progress in Related Industry
    13.2 Consumer Needs Trend/Customer Preference
    13.3 External Environmental Change
        13.3.1 Economic Fluctuations
        13.3.2 Other Risk Factors

14 Research Finding/Conclusion

15 Appendix
    Methodology
    Analyst Introduction
    Data Source


List of Tables and Figures

    Figure Global Glioblastoma Multiforme Treatment Market Size (Million USD) Status and Outlook (2013-2018)
    Table Global Glioblastoma Multiforme Treatment Revenue (Million USD) Comparison by Regions (2013-2018)
    Figure Global Glioblastoma Multiforme Treatment Market Share by Regions (2013-2018)
    Figure United States Glioblastoma Multiforme Treatment Market Size (Million USD) and Growth Rate by Regions (2013-2018)
    Figure EU Glioblastoma Multiforme Treatment Market Size (Million USD) and Growth Rate by Regions (2013-2018)
    Figure Japan Glioblastoma Multiforme Treatment Market Size (Million USD) and Growth Rate by Regions (2013-2018)
    Figure China Glioblastoma Multiforme Treatment Market Size (Million USD) and Growth Rate by Regions (2013-2018)
    Figure India Glioblastoma Multiforme Treatment Market Size (Million USD) and Growth Rate by Regions (2013-2018)
    Figure Southeast Asia Glioblastoma Multiforme Treatment Market Size (Million USD) and Growth Rate by Regions (2013-2018)
    Table Global Glioblastoma Multiforme Treatment Revenue (Million USD) and Growth Rate (%) Comparison by Product (2013-2018)
    Figure Global Glioblastoma Multiforme Treatment Revenue Market Share by Type in 2017
    Figure Bevacizumab (Avastin) Market Size (Million USD) and Growth Rate (2013-2018)
    Figure Carmustine (BiCNU) Market Size (Million USD) and Growth Rate (2013-2018)
    Figure Temozolomide (Temodar and Temodal and Temcad) Market Size (Million USD) and Growth Rate (2013-2018)
    Figure Global Glioblastoma Multiforme Treatment Market Share by Application in 2017
    Figure Glioblastoma Multiforme Treatment Market Size (Million USD) and Growth Rate in Hospital (2013-2018)
    Figure Glioblastoma Multiforme Treatment Market Size (Million USD) and Growth Rate in Clinic (2013-2018)
    Figure Glioblastoma Multiforme Treatment Market Size (Million USD) and Growth Rate in Others (2013-2018)
    Table Glioblastoma Multiforme Treatment Market Size (Million USD) by Players (2013-2018)
    Figure Glioblastoma Multiforme Treatment Market Size Share by Players in 2013
    Figure Glioblastoma Multiforme Treatment Market Size Share by Players in 2017
    Table AbbVie, Inc Basic Information List
    Table Glioblastoma Multiforme Treatment Business Revenue (Million USD) of AbbVie, Inc (2013-2018)
    Figure AbbVie, Inc Glioblastoma Multiforme Treatment Business Revenue Market Share (2013-2018)
    Table Activartis GmbH Basic Information List
    Table Glioblastoma Multiforme Treatment Business Revenue (Million USD) of Activartis GmbH (2013-2018)
    Figure Activartis GmbH Glioblastoma Multiforme Treatment Business Revenue Market Share (2013-2018)
    Table Agenus Inc Basic Information List
    Table Glioblastoma Multiforme Treatment Business Revenue (Million USD) of Agenus Inc (2013-2018)
    Figure Agenus Inc Glioblastoma Multiforme Treatment Business Revenue Market Share (2013-2018)
    Table Arog Pharmaceuticals, Inc Basic Information List
    Table Glioblastoma Multiforme Treatment Business Revenue (Million USD) of Arog Pharmaceuticals, Inc (2013-2018)
    Figure Arog Pharmaceuticals, Inc Glioblastoma Multiforme Treatment Business Revenue Market Share (2013-2018)
    Table Bristol-Myers Squibb Company Basic Information List
    Table Glioblastoma Multiforme Treatment Business Revenue (Million USD) of Bristol-Myers Squibb Company (2013-2018)
    Figure Bristol-Myers Squibb Company Glioblastoma Multiforme Treatment Business Revenue Market Share (2013-2018)
    Table Cavion LLC Basic Information List
    Table Glioblastoma Multiforme Treatment Business Revenue (Million USD) of Cavion LLC (2013-2018)
    Figure Cavion LLC Glioblastoma Multiforme Treatment Business Revenue Market Share (2013-2018)
    Table Celldex Therapeutics Inc Basic Information List
    Table Glioblastoma Multiforme Treatment Business Revenue (Million USD) of Celldex Therapeutics Inc (2013-2018)
    Figure Celldex Therapeutics Inc Glioblastoma Multiforme Treatment Business Revenue Market Share (2013-2018)
    Table Cortice Biosciences Basic Information List
    Table Glioblastoma Multiforme Treatment Business Revenue (Million USD) of Cortice Biosciences (2013-2018)
    Figure Cortice Biosciences Glioblastoma Multiforme Treatment Business Revenue Market Share (2013-2018)
    Table Exelixis Inc Basic Information List
    Table Glioblastoma Multiforme Treatment Business Revenue (Million USD) of Exelixis Inc (2013-2018)
    Figure Exelixis Inc Glioblastoma Multiforme Treatment Business Revenue Market Share (2013-2018)
    Table F. Hoffmann-La Roche Ltd. Basic Information List
    Table Glioblastoma Multiforme Treatment Business Revenue (Million USD) of F. Hoffmann-La Roche Ltd. (2013-2018)
    Figure F. Hoffmann-La Roche Ltd. Glioblastoma Multiforme Treatment Business Revenue Market Share (2013-2018)
    Table Global Glioblastoma Multiforme Treatment Market Size (Million USD) by Product (2013-2018)
    Figure Global Glioblastoma Multiforme Treatment Revenue Market Share (%) by Product (2013-2018)
    Figure Global Glioblastoma Multiforme Treatment Market Share by Product in 2017
    Table Global Glioblastoma Multiforme Treatment Market Size by Application (2013-2018)
    Figure Global Glioblastoma Multiforme Treatment Revenue Market Share (%) by Application in 2017
    Table Top Consumer/End Users of Glioblastoma Multiforme Treatment
    Figure United States Glioblastoma Multiforme Treatment Market Size (Million USD) and Growth Rate (2013-2018)
    Table United States Glioblastoma Multiforme Treatment Market Size (Million USD) by Players (2013-2018)
    Figure United States Glioblastoma Multiforme Treatment Market Size Share by Players in 2013
    Figure United States Glioblastoma Multiforme Treatment Market Size Share by Players in 2017
    Table United States Glioblastoma Multiforme Treatment Market Size by Application (2013-2018)
    Figure United States Glioblastoma Multiforme Treatment Revenue Market Share (%) by Application (2013-2018)
    Figure United States Glioblastoma Multiforme Treatment Market Size Share by Application in 2017
    Figure EU Glioblastoma Multiforme Treatment Market Size (Million USD) and Growth Rate (2013-2018)
    Table EU Glioblastoma Multiforme Treatment Market Size (Million USD) by Players (2013-2018)
    Figure EU Glioblastoma Multiforme Treatment Market Size Share by Players in 2013
    Figure EU Glioblastoma Multiforme Treatment Market Size Share by Players in 2017
    Table EU Glioblastoma Multiforme Treatment Market Size by Application (2013-2018)
    Figure EU Glioblastoma Multiforme Treatment Revenue Market Share (%) by Application (2013-2018)
    Figure EU Glioblastoma Multiforme Treatment Market Size Share by Application in 2017
    Figure Japan Glioblastoma Multiforme Treatment Market Size (Million USD) and Growth Rate (2013-2018)
    Table Japan Glioblastoma Multiforme Treatment Market Size (Million USD) by Players (2013-2018)
    Figure Japan Glioblastoma Multiforme Treatment Market Size Share by Players in 2013
    Figure Japan Glioblastoma Multiforme Treatment Market Size Share by Players in 2017
    Table Japan Glioblastoma Multiforme Treatment Market Size by Application (2013-2018)
    Figure Japan Glioblastoma Multiforme Treatment Revenue Market Share (%) by Application (2013-2018)
    Figure Japan Glioblastoma Multiforme Treatment Market Size Share by Application in 2017
    Figure China Glioblastoma Multiforme Treatment Market Size (Million USD) and Growth Rate (2013-2018)
    Table China Glioblastoma Multiforme Treatment Market Size (Million USD) by Players (2013-2018)
    Figure China Glioblastoma Multiforme Treatment Market Size Share by Players in 2013
    Figure China Glioblastoma Multiforme Treatment Market Size Share by Players in 2017
    Table China Glioblastoma Multiforme Treatment Market Size by Application (2013-2018)
    Figure China Glioblastoma Multiforme Treatment Revenue Market Share (%) by Application (2013-2018)
    Figure China Glioblastoma Multiforme Treatment Market Size Share by Application in 2017
    Figure India Glioblastoma Multiforme Treatment Market Size (Million USD) and Growth Rate (2013-2018)
    Table India Glioblastoma Multiforme Treatment Market Size (Million USD) by Players (2013-2018)
    Figure India Glioblastoma Multiforme Treatment Market Size Share by Players in 2013
    Figure India Glioblastoma Multiforme Treatment Market Size Share by Players in 2017
    Table India Glioblastoma Multiforme Treatment Market Size by Application (2013-2018)
    Figure India Glioblastoma Multiforme Treatment Revenue Market Share (%) by Application (2013-2018)
    Figure India Glioblastoma Multiforme Treatment Market Size Share by Application in 2017
    Figure Southeast Asia Glioblastoma Multiforme Treatment Market Size (Million USD) and Growth Rate (2013-2018)
    Table Southeast Asia Glioblastoma Multiforme Treatment Market Size (Million USD) by Players (2013-2018)
    Figure Southeast Asia Glioblastoma Multiforme Treatment Market Size Share by Players in 2013
    Figure Southeast Asia Glioblastoma Multiforme Treatment Market Size Share by Players in 2017
    Table Southeast Asia Glioblastoma Multiforme Treatment Market Size by Application (2013-2018)
    Figure Southeast Asia Glioblastoma Multiforme Treatment Revenue Market Share (%) by Application (2013-2018)
    Figure Southeast Asia Glioblastoma Multiforme Treatment Market Size Share by Application in 2017
    Figure Global Glioblastoma Multiforme Treatment Market Size and Growth Rate (2018-2025)
    Table Global Glioblastoma Multiforme Treatment Market Size (Million USD) by Regions (2018-2025)
    Figure Global Glioblastoma Multiforme Treatment Market Size Share (2018-2025)
    Figure Global Glioblastoma Multiforme Treatment Market Size Share by Regions in 2025
    Figure United States Glioblastoma Multiforme Treatment Revenue (Million USD) and Growth Rate (2018-2025)
    Figure EU Glioblastoma Multiforme Treatment Revenue (Million USD) and Growth Rate (2018-2025)
    Figure Japan Glioblastoma Multiforme Treatment Revenue (Million USD) and Growth Rate (2018-2025)
    Figure China Glioblastoma Multiforme Treatment Revenue (Million USD) and Growth Rate (2018-2025)
    Figure India Glioblastoma Multiforme Treatment Revenue (Million USD) and Growth Rate (2018-2025)
    Figure Southeast Asia Glioblastoma Multiforme Treatment Revenue (Million USD) and Growth Rate (2018-2025)
    Table Global Glioblastoma Multiforme Treatment Market Size (Million USD) by Type (2018-2025)
    Figure Global Glioblastoma Multiforme Treatment Market Size Share by Type in 2018
    Figure Global Glioblastoma Multiforme Treatment Market Size Share by Type in 2025
    Table Global Glioblastoma Multiforme Treatment Market Size (Million USD) by Application (2018-2025)
    Figure Global Glioblastoma Multiforme Treatment Market Size (Million USD) by Application in 2018
    Figure Global Glioblastoma Multiforme Treatment Market Size (Million USD) by Application in 2025



LATEST NEWS

Microsoft And Walgreen Alliance To Help Healthcare Market To Propel
 25-Feb-2019  /   Chemicals & Materials

The alliance between two or more unrelated business organizations has been pushing the market to the next level by supporting each other. Currently, Amazon has been expanding its business into different markets at global level comprising its e-commerce business, cloud computing, and healthcare also. Amazon is frightening above mentioned markets-based players to tie up for future survival.

New Turmeric Product Is Going To Enter The Global Spices Market
 25-Feb-2019  /   Chemicals & Materials

An innovative agricultural product prepared from turmeric, specifically grown in Belize, has entered the market with high customer demand. The product is gaining popularity in Canada and other regions of the Caribbean, along with Belize. This might facilitate the steep growth of global spices market. This discovery will not only expand the agricultural market capitalization but also increase th ...

Drop In Cashew Export Owing To Quality Issues Likely To Hamper Cashew Market Growth
 13-Feb-2019  /   Food & Beverage

A major glut along with poor turnover was confronted by merchants, traders, farmers, and other financiers in the cashew market in Kogi State in the 2018 farming season caused by heavy losses summed over N50 Billion. Kogi is the largest cashew-making state in Nigeria, shipping around 100 metric tonnes of cashew nuts out of the 220 metric tonnes exported by the whole nation yearly.






Our Clients

We are here to help you Get in touch quickly.

48 hours! That’s all you need to get a detailed market research of any specific industry.

/